Solara Active Pharma Sciences reports consolidated net loss of Rs 10.10 crore in the September 2025 quarter
(05 Nov 2025)

Back
Net loss of Solara Active Pharma Sciences reported to Rs 10.10 crore in the quarter ended September 2025 as against net profit of Rs 8.01 crore during the previous quarter ended September 2024. Sales declined 9.63% to Rs 313.54 crore in the quarter ended September 2025 as against Rs 346.95 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales313.54346.95 -10
OPM %11.0817.67 -
PBDT14.3933.35 -57
PBT-10.108.01 PL
NP-10.108.01 PL

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew